Ed O'Keefe is CBS News' senior White House and political correspondent reporting for all CBS News platforms. He's part of the team covering President Trump and covered all four years of Joe Biden's ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Rubraca is now FDA-approved for BRCA mutation-associated mCRPC after prior androgen receptor-directed therapy, confirming its efficacy in the TRITON3 trial. The TRITON3 trial showed Rubraca ...

Speaking recently to ESPN, the 65-year-old coach discussed his diagnosis, which came earlier this year, and how he’s used his own experiences to inspire players in the face of adversity. “Stuff ...

The Avera Cancer Institute in Pierre has recently added an advanced surface-guided radiation therapy system to enhance ...

A leading doctor has addressed common questions about prostate cancer in a bid to distinguish facts from fiction. His thoughts come as more than 63,000 men are diagnosed each year, according to ...

Mr. Sasse, a former senator from Nebraska, announced that he had received a diagnosis last week for Stage 4 pancreatic cancer. By Adeel Hassan Charles Homans and Stephanie Saul Ben Sasse, a Republican ...

You’ve probably seen Lichtenberg figures before, those lightning-like traces left by high-voltage discharge. The safe way to create them is using an electron beam to embed charge inside an acrylic ...